Moreover, other studies have found that autophagy in CRC cells can effectively promote chemoresistance in CRCSCs by activating GSK-3β/Wnt/β-linked protein signaling to enhance resistance to CRC therapy, whereas PIK3C3/VPS34 inhibitors can increase the efficacy of CRC therapy [59]. The gene discussed is PIK3C3; the disease is colorectal carcinoma.